Evelien Gielen - Concepedia

Author

Evelien Gielen

Also Known As

A De Spiegeleer, E Gielen, E. Gielen, E., Gielen, Evelien Gielen, Eveline Gielen, GIELEN E, Gielen Evelien, Gielen, Evelien, Herman Borghs

195

Publications

7.4K

Citations

H-Index

Concepts

All Affiliations

KU Leuven Universitair Ziekenhuis Leuven University of Manchester Imperial College London Medical University of Lodz

About

Evelien Gielen is an author at KU Leuven specializing in medicine, osteoporosis, and bone health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	982
2	Health Sciences	8	8	571
3	Public Health	3	3	196
4	Anatomy	1	1	71
5	Clinical Nutrition	1	1	14

Evelien Gielen

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men Sabine Verschueren, Evelien Gielen, Terence W O’Neill, Osteoporosis International Bone HealthBody CompositionGeriatricsBone Mineral DensityOsteoporosis	2012	297
Optimal Vitamin D Status: A Critical Analysis on the Basis of Evidence-Based Medicine Roger Bouillon, Natasja M. van Schoor, Evelien Gielen, The Journal of Clinical Endocrinology & Metabolism	2013	273
One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study E. Michael Lewiecki, Rajani Dinavahi, Marise Lazaretti-Castro, Journal of Bone and Mineral Research SclerostinBone ResorptionOsteoporosisInflammatory ArthritisOrthopaedic Surgery	2018	183
Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis Michaël R. Laurent, Geoffrey L. Hammond, Marco Blokland, Scientific Reports	2016	162
The ability of three different models of frailty to predict all-cause mortality: Results from the European Male Aging Study (EMAS) Rathi Ravindrarajah, David M. Lee, Stephen R. Pye, Archives of Gerontology and Geriatrics All-cause MortalityAgingDifferent ModelsGeriatricsLongevity	2013	149
Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab David L. Kendler, Henry G. Bone, Francesco Massari, Osteoporosis International	2019	116
Endocrine determinants of incident sarcopenia in middle-aged and elderly European men Evelien Gielen, Terence W O’Neill, Stephen R. Pye, Journal of Cachexia Sarcopenia and Muscle	2015	95
Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study Peyman Hadji, Evelien Gielen, Maurille Feudjo Tepie, Osteoporosis International	2015	92
The association of frailty with serum 25-hydroxyvitamin D and parathyroid hormone levels in older European men Abdelouahid Tajar, David M. Lee, Stephen R. Pye, Age and Ageing	2012	92
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease Paul D. Miller, Jonathan D. Adachi, Ben‐Hur Albergaria, Journal of Bone and Mineral Research	2020	87

Page 1